These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 26620604

  • 1. [Assessment of 2 automated microdilution techniques compared to an agar dilution method in determining sensitivity to fosfomycin in strains of carbapenem-resistant Pseudomonas aeruginosa].
    Gil-Romero Y, Regodón-Domínguez M, Wilhelmi de Cal I, López-Fabal F, Gómez-Garcés JL.
    Enferm Infecc Microbiol Clin; 2016; 34(7):406-8. PubMed ID: 26620604
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vitro activity of fosfomycin against a collection of clinical Pseudomonas aeruginosa isolates from 16 Spanish hospitals: establishing the validity of standard broth microdilution as susceptibility testing method.
    Díez-Aguilar M, Morosini MI, del Campo R, García-Castillo M, Zamora J, Cantón R.
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5701-3. PubMed ID: 23939889
    [Abstract] [Full Text] [Related]

  • 4. Performance of Four Fosfomycin Susceptibility Testing Methods against an International Collection of Clinical Pseudomonas aeruginosa Isolates.
    Smith EC, Brigman HV, Anderson JC, Emery CL, Bias TE, Bergen PJ, Landersdorfer CB, Hirsch EB.
    J Clin Microbiol; 2020 Sep 22; 58(10):. PubMed ID: 32669380
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Is a New Standard Needed for Diffusion Methods for In Vitro Susceptibility Testing of Fosfomycin against Pseudomonas aeruginosa?
    Díez-Aguilar M, Martínez-García L, Cantón R, Morosini MI.
    Antimicrob Agents Chemother; 2016 Feb 22; 60(2):1158-61. PubMed ID: 26643341
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Shall we report the carbapenem resistance in Pseudomonas aeruginosa and Acinetobacter baumannii strains detected by BD Phoenix system?].
    Oğünç D, Ongüt G, Ozen NS, Baysan BO, Günseren F, Dağlar D, Demirbakan H, Gültekin M.
    Mikrobiyol Bul; 2010 Apr 22; 44(2):197-202. PubMed ID: 20549953
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antimicrobial activity of fosfomycin against multidrug-resistant Pseudomonas aeruginosa in vitro.
    Kobayashi Y, Sumitani Y, Sugita K, Aikawa N.
    Int J Antimicrob Agents; 2007 Dec 22; 30(6):563-4. PubMed ID: 17900870
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Susceptibility of multiresistant gram-negative bacteria to fosfomycin and performance of different susceptibility testing methods.
    Perdigão-Neto LV, Oliveira MS, Rizek CF, Carrilho CM, Costa SF, Levin AS.
    Antimicrob Agents Chemother; 2014 Dec 22; 58(3):1763-7. PubMed ID: 24323469
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.